164 related articles for article (PubMed ID: 26680586)
41. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
42. Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks.
Han RW; Zhang RS; Xu HJ; Chang M; Peng YL; Wang R
Neuropharmacology; 2013 Jul; 70():261-7. PubMed ID: 23454528
[TBL] [Abstract][Full Text] [Related]
43. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
[TBL] [Abstract][Full Text] [Related]
44. The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions.
Botticelli L; Micioni Di Bonaventura E; Ubaldi M; Ciccocioppo R; Cifani C; Micioni Di Bonaventura MV
Pharmaceuticals (Basel); 2021 Mar; 14(4):. PubMed ID: 33810221
[TBL] [Abstract][Full Text] [Related]
45. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor.
Ruzza C; Pulga A; Rizzi A; Marzola G; Guerrini R; Calo' G
Neuropharmacology; 2012 Apr; 62(5-6):1999-2009. PubMed ID: 22248636
[TBL] [Abstract][Full Text] [Related]
46. Neuropeptide-S-receptor deficiency affects sex-specific modulation of safety learning by pre-exposure to electric stimuli.
Kreutzmann JC; Khalil R; Köhler JC; Mayer D; Florido A; Nadal R; Andero R; Fendt M
Genes Brain Behav; 2020 Mar; 19(3):e12621. PubMed ID: 31661603
[TBL] [Abstract][Full Text] [Related]
47. Neuropeptide S: a new player in the modulation of arousal and anxiety.
Reinscheid RK; Xu YL; Civelli O
Mol Interv; 2005 Feb; 5(1):42-6. PubMed ID: 15731503
[TBL] [Abstract][Full Text] [Related]
48. Neuropeptide S Displays as a Key Neuromodulator in Olfactory Spatial Memory.
Wang C; Xin L; Cai CC; Cong CY; Xie JF; Kong XP; Dong CY; Li J; Cui GF; Chen HL; Ren YL; Shao YF; Hou YP
Chem Senses; 2020 Apr; 45(3):195-202. PubMed ID: 32010937
[TBL] [Abstract][Full Text] [Related]
49. Neuropeptide S Increases locomotion activity through corticotropin-releasing factor receptor 1 in substantia nigra of mice.
Li MS; Peng YL; Jiang JH; Xue HX; Wang P; Zhang PJ; Han RW; Chang M; Wang R
Peptides; 2015 Sep; 71():196-201. PubMed ID: 26239581
[TBL] [Abstract][Full Text] [Related]
50. Neuropeptide S reduces propofol- or ketamine-induced slow wave states through activation of cognate receptors in the rat.
Kong XP; Wang C; Xie JF; Zhao P; Dai LR; Shao YF; Lin JS; Hou YP
Neuropeptides; 2017 Jun; 63():59-66. PubMed ID: 28228241
[TBL] [Abstract][Full Text] [Related]
51. Neuropeptide S: a transmitter system in the brain regulating fear and anxiety.
Pape HC; Jüngling K; Seidenbecher T; Lesting J; Reinscheid RK
Neuropharmacology; 2010 Jan; 58(1):29-34. PubMed ID: 19523478
[TBL] [Abstract][Full Text] [Related]
52. Sociability and extinction of conditioned social fear is affected in neuropeptide S receptor-deficient mice.
Kolodziejczyk MH; Faesel N; Koch M; Fendt M
Behav Brain Res; 2020 Sep; 393():112782. PubMed ID: 32585300
[TBL] [Abstract][Full Text] [Related]
53. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.
Lennertz L; Quednow BB; Schuhmacher A; Petrovsky N; Frommann I; Schulze-Rauschenbach S; Landsberg MW; Steinbrecher A; Höfels S; Pukrop R; Klosterkötter J; Franke PE; Wölwer W; Gaebel W; Häfner H; Maier W; Wagner M; Mössner R
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1205-15. PubMed ID: 22078257
[TBL] [Abstract][Full Text] [Related]
54. Neuropeptide S Counteracts Paradoxical Sleep Deprivation-Induced Anxiety-Like Behavior and Sleep Disturbances.
Xie JF; Shao YF; Wang HL; Wang C; Cui GF; Kong XP; Wang LX; Chen YN; Cong CY; Chen HL; Hou YP
Front Cell Neurosci; 2018; 12():64. PubMed ID: 29559896
[TBL] [Abstract][Full Text] [Related]
55. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
[TBL] [Abstract][Full Text] [Related]
56. Can Neuropeptide S Be an Indicator for Assessing Anxiety in Psychiatric Disorders?
Markiewicz-Gospodarek A; Kuszta P; Baj J; Dobrowolska B; Markiewicz R
Front Public Health; 2022; 10():872430. PubMed ID: 35558538
[TBL] [Abstract][Full Text] [Related]
57. Evolutionary history of the neuropeptide S receptor/neuropeptide S system.
Valsalan R; Manoj N
Gen Comp Endocrinol; 2014 Dec; 209():11-20. PubMed ID: 24859256
[TBL] [Abstract][Full Text] [Related]
58. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects.
Lukas M; Neumann ID
Neuropharmacology; 2012 Jan; 62(1):398-405. PubMed ID: 21871467
[TBL] [Abstract][Full Text] [Related]
59. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain.
Okamura N; Garau C; Duangdao DM; Clark SD; Jüngling K; Pape HC; Reinscheid RK
Neuropsychopharmacology; 2011 Mar; 36(4):744-52. PubMed ID: 21150909
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
